Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational StudyFrancesco Bellinato, Giampiero Girolomoni, Stefano Piaserico et al.|Vaccines|2023Cited by 22
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis)Luigi Gargiulo, Alessandra Narcisi, Diego Orsini et al.|Journal of Dermatological Treatment|2024Cited by 21